The north and south of candidemia: Issues for Latin America.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Drugs of Today

• Publication date

  2008-09-01

• Fields of study

  Medicine

• Identifiers
  PMID 18810276
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neonatal candidiasis.

  2020cited by this paper
• Posaconazole

  2012cited by this paper
• Management of Candida infections in the adult intensive care unit

  2008cited by this paper
• Geographic and Temporal Trends in Isolation and Antifungal Susceptibility of Candida parapsilosis: a Global Assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005

  2008cited by this paper
• Yeast identification--past, present, and future methods.

  2007cited by this paper
• A multicenter, randomized trial of prophylactic fluconazole in preterm neonates.

  2007cited by this paper
• Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2005: an 8.5-Year Analysis of Susceptibilities of Candida Species and Other Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing

  2007cited by this paper
• Paradoxical Growth Effect of Caspofungin Observed on Biofilms and Planktonic Cells of Five Different Candida Species

  2007cited by this paper
• Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.

  2007cited by this paper
• Prospective Observational Study of Candidemia in São Paulo, Brazil: Incidence Rate, Epidemiology, and Predictors of Mortality

  2007cited by this paper
• Anidulafungin versus fluconazole for invasive candidiasis.

  2007cited by this paper
• Serum Differentially Alters the Antifungal Properties of Echinocandin Drugs

  2007cited by this paper
• Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients

  2007cited by this paper
• Correlation of the MIC and Dose/MIC Ratio of Fluconazole to the Therapeutic Response of Patients with Mucosal Candidiasis and Candidemia

  2007cited by this paper
• Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.

  2007cited by this paper
• Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem

  2007cited by this paper
• In Vitro Susceptibility of Invasive Isolates of Candida spp. to Anidulafungin, Caspofungin, and Micafungin: Six Years of Global Surveillance

  2007cited by this paper
• Antifungal therapy for neonatal candidiasis

  2007cited by this paper
• Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.

  2007cited by this paper
• Is the Volume of Blood Cultured Still a Significant Factor in the Diagnosis of Bloodstream Infections?

  2007cited by this paper
• Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial.

  2007cited by this paper
• In Vivo Efficacy of Anidulafungin and Caspofungin against Candida glabrata and Association with In Vitro Potency in the Presence of Sera

  2007cited by this paper
• Antifungal susceptibility of 1000 Candida bloodstream isolates to 5 antifungal drugs: results of a multicenter study conducted in São Paulo, Brazil, 1995-2003.

  2007cited by this paper
• Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection.

  2007cited by this paper
• Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial).

  2007cited by this paper
• In Vitro Susceptibility of Breakthrough Candida Bloodstream Isolates Correlates with Daily and Cumulative Doses of Fluconazole

  2006cited by this paper
• Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases.

  2006cited by this paper
• Invasive candidiasis.

  2006cited by this paper
• Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials.

  2006cited by this paper
• Antifungal Prophylaxis to Prevent Neonatal Candidiasis: A Survey of Perinatal Physician Practices

  2006cited by this paper
• Voriconazole Therapeutic Drug Monitoring

  2006cited by this paper
• Treatment options of invasive fungal infections in adults.

  2006cited by this paper
• Posaconazole as Salvage Therapy for Zygomycosis

  2006cited by this paper
• Interpretive Breakpoints for Fluconazole and Candida Revisited: a Blueprint for the Future of Antifungal Susceptibility Testing

  2006cited by this paper
• Evaluation of Amphotericin B Interpretive Breakpoints for Candida Bloodstream Isolates by Correlation with Therapeutic Outcome

  2006cited by this paper
• Epidemiology of Candidemia in Brazil: a Nationwide Sentinel Surveillance of Candidemia in Eleven Medical Centers

  2006cited by this paper
• Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints

  2006cited by this paper
• Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.

  2006cited by this paper
• Anidulafungin: a novel echinocandin.

  2006cited by this paper
• Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?

  2006cited by this paper
• Micafungin: a new echinocandin.

  2006cited by this paper
• Role of antifungal susceptibility testing in patient management

  2006cited by this paper
• Caspofungin for refractory candidemia in neonates.

  2006cited by this paper
• Assessment of the Paradoxical Effect of Caspofungin in Therapy of Candidiasis

  2006cited by this paper
• Current treatment strategies for disseminated candidiasis.

  2006cited by this paper
• Pharmacokinetic and Maximum Tolerated Dose Study of Micafungin in Combination with Fluconazole versus Fluconazole Alone for Prophylaxis of Fungal Infections in Adult Patients Undergoing a Bone Marrow or Peripheral Stem Cell Transplant

  2005cited by this paper
• The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis.

  2005cited by this paper
• Activity of posaconazole in the treatment of central nervous system fungal infections.

  2005cited by this paper
• Caspofungin Susceptibility Testing of Isolates from Patients with Esophageal Candidiasis or Invasive Candidiasis: Relationship of MIC to Treatment Outcome

  2005cited by this paper
• Phenotypic and genotypic evaluation of fluconazole resistance in vaginal Candida strains isolated from HIV-infected women from Brazil.

  2005cited by this paper
• Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality

  2005cited by this paper
• Candida orthopsilosis and Candida metapsilosis spp. nov. To Replace Candida parapsilosis Groups II and III

  2005cited by this paper
• Mechanisms of Azole Resistance in Clinical Isolates of Candida glabrata Collected during a Hospital Survey of Antifungal Resistance

  2005cited by this paper
• Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical Candida sp. Isolates

  2005cited by this paper
• Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial.

  2005cited by this paper
• Epidemiology and Predictors of Mortality in Cases of Candida Bloodstream Infection: Results from Population-Based Surveillance, Barcelona, Spain, from 2002 to 2003

  2005cited by this paper
• Voriconazole for candidosis: an important addition?

  2005cited by this paper
• Candida albicans biofilms: more than filamentation.

  2005cited by this paper
• Multiechinocandin- and Multiazole-Resistant Candida parapsilosis Isolates Serially Obtained during Therapy for Prosthetic Valve Endocarditis

  2005cited by this paper
• Pharmacokinetics, Safety, and Tolerability of Caspofungin in Children and Adolescents

  2005cited by this paper
• Fluconazole prophylaxis in critically ill surgical patients: A meta-analysis*

  2005cited by this paper
• Anidulafungin: a new echinocandin with a novel profile.

  2005cited by this paper
• Multicenter Evaluation of a Candida albicans Peptide Nucleic Acid Fluorescent In Situ Hybridization Probe for Characterization of Yeast Isolates from Blood Cultures

  2005cited by this paper
• Laboratory diagnosis of invasive candidiasis.

  2005cited by this paper
• Epidemiology of Candidaemia in Europe: Results of 28-Month European Confederation of Medical Mycology (ECMM) Hospital-Based Surveillance Study

  2004cited by this paper
• Caspofungin Therapy of Neonates With Invasive Candidiasis

  2004cited by this paper
• Evaluation of fluconazole resistance mechanisms in candida albicans clinical isolates from HIV-infected patients in Brazil.

  2004cited by this paper
• Pharmacokinetics/pharmacodynamics of echinocandins

  2004cited by this paper
• Clinical trials of antifungal prophylaxis among patients undergoing surgery.

  2004cited by this paper
• Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.

  2004cited by this paper
• Direct Comparison of the BACTEC 9240 and BacT/ALERT 3D Automated Blood Culture Systems for Candida Growth Detection

  2004cited by this paper
• Clinical Evaluation of the Sensititre YeastOne Colorimetric Antifungal Plate for Antifungal Susceptibility Testing of the New Triazoles Voriconazole, Posaconazole, and Ravuconazole

  2004cited by this paper
• Guidelines for treatment of candidiasis.

  2004cited by this paper
• Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans.

  2004cited by this paper
• Incidence of Bloodstream Infections Due to Candida Species and In Vitro Susceptibilities of Isolates Collected from 1998 to 2000 in a Population-Based Active Surveillance Program

  2004cited by this paper
• Invasive fungal infections in Chile: a multicenter study of fungal prevalence and susceptibility during a 1-year period.

  2004cited by this paper
• Caspofungin Resistance in Candida albicans: Correlating Clinical Outcome with Laboratory Susceptibility Testing of Three Isogenic Isolates Serially Obtained from a Patient with Progressive Candida Esophagitis

  2004cited by this paper
• Mechanism of Increased Fluconazole Resistance in Candida glabrata during Prophylaxis

  2004cited by this paper
• Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida.

  2004cited by this paper
• Pharmacokinetics of voriconazole in the cerebrospinal fluid of an immunocompromised patient with a brain abscess due to Aspergillus fumigatus.

  2004cited by this paper
• Disk Diffusion-Based Methods for Determining Candida parapsilosis Susceptibility to Anidulafungin

  2003cited by this paper
• Treatment of fungal infections in hematology and oncology

  2003cited by this paper
• High-Dose Liposomal Amphotericin B in the Therapy of Systemic Candidiasis in Neonates

  2003cited by this paper
• Antifungal Susceptibility Survey of 2,000 Bloodstream Candida Isolates in the United States

  2003cited by this paper
• Ketoconazole alters cyclosporine pharmacokinetic profile and may predispose to acute rejection.

  2003cited by this paper
• Antifungal pharmacotherapy for neonatal candidiasis.

  2003cited by this paper
• A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.

  2003cited by this paper
• Voriconazole treatment for less-common, emerging, or refractory fungal infections.

  2003cited by this paper
• Neonatal Invasive Candidiasis: A Prospective Multicenter Study of 118 Cases

  2003cited by this paper
• Caspofungin.

  2003cited by this paper
• Echinocandin antifungal drugs.

  2003cited by this paper
• [Guidelines for the treatment of infection due to Aspergillus spp].

  2003cited by this paper
• Epidemiology of Candida species infections in critically ill non-immunosuppressed patients.

  2003cited by this paper
• Treatment of candidaemia in premature infants: comparison of three amphotericin B preparations.

  2003cited by this paper
• Amphotericin B: time for a new "gold standard".

  2003cited by this paper
• Mechanism of Fluconazole Resistance in Candida albicans Biofilms: Phase-Specific Role of Efflux Pumps and Membrane Sterols

  2003cited by this paper
• Correlation between E-Test, Disk Diffusion, and Microdilution Methods for Antifungal Susceptibility Testing of Fluconazole and Voriconazole

  2003cited by this paper
• Genetic Basis for Differential Activities of Fluconazole and Voriconazole against Candida krusei

  2003cited by this paper
• Caspofungin: the first representative of a new antifungal class.

  2003cited by this paper
• Continuous infusion of escalated doses of amphotericin B deoxycholate: an open-label observational study.

  2003cited by this paper

• Comparison of virulence factors between invasive and non-invasive clinical isolates of Candida spp.

  2025cites this paper
• Invasive Candidiasis in Contexts of Armed Conflict, High Violence, and Forced Displacement in Latin America and the Caribbean (2005–2025)

  2025influential citation
• Association between Candida biofilm-forming bloodstream isolates and the clinical evolution in patients with candidemia: An observational nine-year single center study in Mexico.

  2017cites this paper
• Efficacy of anidulafungin in 539 patients with invasive candidiasis: a patient-level pooled analysis of six clinical trials

  2017cites this paper
• Real life study of three years omalizumab in patients with difficult-to-control asthma.

  2015cites this paper
• Prevalence and Fluconazole Susceptibility Profile of Candida spp. Clinical Isolates in a Brazilian Tertiary Hospital in Minas Gerais, Brazil.

  2015cites this paper
• Clinical and epidemiological characteristics and risk factors for mortality in patients with candidemia in hospitals from Bogotá, Colombia

  2014cites this paper
• Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period

  2014cites this paper
• linical and epidemiological characteristics and isk factors for mortality in patients with andidemia in hospitals from Bogotá , Colombia orge

  2014cites this paper
• Caracterização do complexo Candida glabrata em isolados de hemocultura e avaliação da sensibilidade a antifúngicos

  2014cites this paper
• An open‐label study of anidulafungin for the treatment of candidaemia/invasive candidiasis in Latin America

  2014cites this paper
• A quick and low-cost PCR-based assay for Candida spp. identification in positive blood culture bottles

  2013cites this paper
• Is the incidence of candidemia caused by Candida glabrata increasing in Brazil? Five-year surveillance of Candida bloodstream infection in a university reference hospital in southeast Brazil.

  2013cites this paper
• Historical trends in the epidemiology of candidaemia: analysis of an 11-year period in a tertiary care hospital in Brazil.

  2013influential citation
• Pharmacokinetics of Micafungin in Adult Patients with Invasive Candidiasis and Candidemia

  2012cites this paper
• Fungal bloodstream infections in tertiary care hospitals in Colombia.

  2011cites this paper
• Caracterização clínica e epidemiológica das infecções de corrente sanguínea causadas por Candida spp. no Hospital São Paulo

  2010cites this paper
• Geographic Trends in Invasive Candidiasis

  2010cites this paper
• [Stoutness and prognosis of female non-metastatic breast cancer: results from a French observational cohort study].

  2009cites this paper